Cardiovascular Devices are used in treating diseases related to the heart and the circulatory system. A Coronary Stent is an expandable perforated tube that is inserted into a natural conduit of the body to prevent or counteract disease-induced localized flow constriction. GlobalData uses proprietary data and analytics to provide a comprehensive report on the coronary stents devices market, including market shares of different players within South Africa. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the coronary stents market in South Africa was Abbott Laboratories followed by Boston Scientific, Biotronik SE, Medtronic, Lepu Medical Technology (Beijing), Meril Life Sciences, Sahajanand Medical Technologies, Translumina Therapeutics and MicroPort Scientific.
The main goal of a stent is to hold the inner wall in its compressed position and retain the enlarged vessel diameter. Coronary Stents are used in the coronary vasculature and include Bioabsorbable Stents (BAS), Drug Eluting Stents (DES), Bare Metal Stents (BMS) and Covered Stents. A Coronary Stent System consists of a stent and a balloon catheter delivery system. Coronary Bare Metal Stents are uncoated stents that are permanently placed inside the artery. Coronary Drug Eluting Stents release drugs locally and can be coated with a polymeric material. Coronary Covered Stents have a metal skeleton with an additional accessory or cover made of fabric or graft material. Coronary Bioabsorbable Stents are also known as Bioresorbable or Biodegradable Coronary Stents.
The value of the coronary stents devices market within South Africa was expected to be over $30m in 2023.
For the latest complete market share analysis of coronary stents device market in South Africa, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
